SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
22-Feb-24 4:05 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 20-Feb-24 | Market Sale (Planned) | 2,153 | $9.56 | $20,582.70 | (3%) 62.46K to 60.31K | (18%) |
19-Jan-24 4:21 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 18-Jan-24 | Grant | 21,835 | -- | -- | 54% 40.63K to 62.46K | |
08-Aug-23 9:05 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 08-Aug-23 | Sale (Planned) | 11 | $8.93 | $98.23 | (< 1%) 40.64K to 40.63K | |
08-Aug-23 9:05 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 07-Aug-23 | Sale (Planned) | 2,385 | $9.52 | $22,705.20 | (6%) 43.02K to 40.64K | |
30-Jan-23 4:30 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 26-Jan-23 | Grant | 17,375 | -- | -- | 68% 25.65K to 43.02K | |
14-Nov-22 7:43 AM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 09-Nov-22 | Payment of Exercise | 1,505 | $4.70 | $7,073.50 | (6%) 27.15K to 25.65K |